Noble Herbal Drugs Consortium Producer Company Limited
Founded in 2008 and headquartered in Tamil Nadu, India.
2008 | Tiruvallur, Tamil Nadu (India) | Inactive
Noble Herbal Drugs Consortium Producer Company Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.14 M
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2011
About Noble Herbal Drugs Consortium Producer Company
Noble Herbal Drugs Consortium Producer Company Limited (NHDCPCL) is Strike Off company established on 09 Jun 2008 with its office registered at Tiruvallur, Tamil Nadu, India and has been running since 16 Year, 8 Months with a paid up capital of 0.14 M. According to MCA records, 7 Directors are linked to this company as of 06 Feb 2024.
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01117TN2008PTC068106
- Company No.
068106
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2008
- Date of AGM
29 Sep 2011
- Date of Balance Sheet
31 Mar 2011
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Agriculture
Who are the key members and board of directors at Noble Herbal Drugs Consortium Producer Company?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Usain Irfandheen  | Director | 09-Jun-2008 | Current |
| Karunakaran Magesh | Director | 09-Jun-2008 | Current |
| Natarajan Krishnasami | Director | 09-Jun-2008 | Current |
| Dharmalingam Thyagarajan | Director | 09-Jun-2008 | Current |
| Kuppusamy Chandrasekaran | Director | 10-Feb-2010 | Current |
| Shanmugam Pugazhenthi | Director | 14-Feb-2013 | Current |
Financial Performance of Noble Herbal Drugs Consortium Producer Company.
Enhance accessibility to Noble Herbal Drugs Consortium Producer Company's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Noble Herbal Drugs Consortium Producer Company?
Unlock access to Noble Herbal Drugs Consortium Producer Company's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Noble Herbal Drugs Consortium Producer Company?
Unlock and access historical data on people associated with Noble Herbal Drugs Consortium Producer Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noble Herbal Drugs Consortium Producer Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noble Herbal Drugs Consortium Producer Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.